Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
about
Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancerWhole Blood Profiling of Bacillus Calmette-Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation.Natural killer cell cytokine response to M. bovis BCG Is associated with inhibited proliferation, increased apoptosis and ultimate depletion of NKp44(+)CD56(bright) cells.Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils.Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guérin vaccine on bladder cancer cells.Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now?Immunotherapy for urothelial carcinoma: current status and perspectives.Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapyPolymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapyGene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.Role of innate cytokines in mycobacterial infection.From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.The bifacial role of helminths in cancer: involvement of immune and non-immune mechanisms.Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies.Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells.Mechanism of monoclonal antibody-coupled Staphylococcus superantigen-A induced apoptosis in human bladder cancer cells.A model for cancer-suppressive inflammationWhat Have We Learnt about BCG Vaccination in the Last 20 Years?Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.The role of bacteria in cancer therapy - enemies in the past, but allies at present.
P2860
Q27346705-296FB94D-A3FC-4640-92F2-37B1668D19DFQ33751253-E432001C-96DA-48D9-B0EB-C2B12663DD0FQ33766076-364E4F40-40B9-4BBF-B618-CDA4D42ED599Q34851503-F21BBBD3-107B-46A9-96EF-5D516ED26732Q34956634-C890B8AA-9B33-4DB3-9F94-0EDC713AA260Q35215350-1FDFC25A-1943-46DC-85A7-9C22853B216CQ35946382-5A839209-5609-4CD7-8BDA-03D1347F6313Q36167778-3B16917D-B4AB-4096-AD06-0FCE75BD676DQ37137381-4340DBCE-A217-44AA-8EAD-DA74EDD8F56EQ37235573-8B3B7E3E-28A4-4EC1-9F25-46963DFF8F72Q37244332-E3FB7919-EB96-478A-883E-AA36FD5CA134Q37828065-069E9C13-736F-4A8E-B7B8-FF407F7FDF84Q37856711-13543B5D-2EE6-4DB5-A67A-53DB05FE5D09Q38142595-38B14B3A-FC2F-4565-9A66-126254F5A8C4Q38192723-902A69FA-A347-4035-9D50-A70C100BB4FCQ38251141-ED07D2B4-D74F-425D-A9FB-91991888D6F4Q39131618-E4B1E3CE-58B8-4D8C-9556-37B556906615Q39504583-89F26C13-60CC-4F0B-8EE5-2DD18BDE3911Q41275639-88FE15D9-11E9-425D-9907-9F2A68E8F0B7Q41684091-8013FFC3-90B1-4719-B504-B8E411C73A22Q47655009-C3E4D3AB-D520-43E2-BFE5-BDD6E91976EAQ53636759-BB4958AE-4DBD-40CE-887C-6FA5CA2BF4A2Q53699248-D9947B1E-7846-4755-9663-16DA40DC3131
P2860
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
@en
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
@nl
type
label
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
@en
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
@nl
prefLabel
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
@en
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
@nl
P2093
P2860
P356
P1433
P1476
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer
@en
P2093
Anton B Alexandroff
Poulam M Patel
Steve Nicholson
P2860
P304
P356
10.2217/IMT.10.32
P577
2010-07-01T00:00:00Z